Nancy J. Kevin

Statistics

Publications

Citations

324

H-Index

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Nancy J. Kevin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and drug design.

Publications per year

1993–2021

Publications

Broadening the Spectrum of β-Lactam Antibiotics through Inhibition of Signal Peptidase Type I

Alex G. Therien, Joann Huber, Kenneth E. Wilson et al. · Antimicrobial Agents and Chemotherapy · 2012 · 78 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

The discovery of sulfonylated dipeptides as Potent VLA-4 antagonists

William K. Hagmann, Philippe L. Durette, Thomas J. Lanza et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II

Salah D. Kivlighn, William R. Huckle, Gloria J. Zingaro et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1995 · 42 citations

Medicine, Cardiology, Pharmacology +15

Direct Arylation of Azoles Enabled by Pd/Cu Dual Catalysis

Tiffany Piou, Yuriy Slutskyy, Nancy J. Kevin et al. · Organic Letters · 2021 · 29 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Subtituted phenylthiophene benzoylsulfonamides with potent binding affinity to angiotensin II AT1 and AT2 receptors

Nancy J. Kevin, Ralph A. Rivero, W. J. GREENLEE et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 11